Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
Asano N, Takeshima H, Yamashita S, Takamatsu H, Hattori N, Kubo T, Yoshida A, Kobayashi E, Nakayama R, Matsumoto M, Nakamura M, Ichikawa H, Kawai A, Kondo T, Ushijima T.
Asano N, et al. Among authors: takeshima h.
Sci Rep. 2019 Dec 30;9(1):20360. doi: 10.1038/s41598-019-56883-0.
Sci Rep. 2019.
PMID: 31889115
Free PMC article.